Keyphrases
Remission
100%
Disease Onset
100%
Blood Glucose
100%
K ATP
100%
Sulfonylurea Therapy
100%
Neonatal Diabetes Mellitus
100%
Stress Diabetes
100%
Insulin Secretion
33%
Glibenclamide
33%
Sulfonylurea
33%
Basal Insulin
33%
Insulin Deficiency
33%
Normal Blood
33%
Insulin Content
33%
Hyperglycemia
16%
Compensatory Mechanisms
16%
Insulin Sensitivity
16%
Disease Progression
16%
Murine Model
16%
Early Intervention
16%
High Dose
16%
Diabetes
16%
Disease Outcome
16%
KATP Channel
16%
Insulin
16%
Glucose Level
16%
Gain-of-function
16%
Islet Function
16%
ATP-dependent
16%
Elevated Blood Glucose
16%
Drinking Water
16%
Insulin Injection
16%
Tight Control
16%
Treatment Cessation
16%
Permanent Form
16%
Medicine and Dentistry
Diabetes
100%
Adenosine Triphosphate
100%
Neonatal Diabetes Mellitus
100%
Sulfonylurea
100%
Diseases
100%
Blood Glucose
83%
Hyperglycemia
33%
Insulin Release
33%
Glibenclamide
33%
Insulin Allergy
33%
Disease Exacerbation
16%
Insulin Sensitivity
16%
Drug Megadose
16%
Research Design
16%
Early Intervention
16%
Potassium Ion
16%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Adenosine Triphosphate
100%
Sulfonylurea
100%
Diabetes Mellitus
100%
Diseases
100%
Hyperglycemia
33%
Glibenclamide
33%
Insulin Allergy
33%
Potassium Ion
16%
Disease Exacerbation
16%
Biochemistry, Genetics and Molecular Biology
Adenosine Triphosphate
100%
Glucose Blood Level
100%
Sulfonylurea
100%
Glibenclamide
33%
Insulin Release
33%
Erethism
33%
Insulin Sensitivity
16%
Hyperglycemia
16%
Drug Megadose
16%
Glucose Level
16%
Neuroscience
Adenosine Triphosphate
100%
Sulfonylurea
100%
Diabetes Mellitus
100%
Glibenclamide
33%
Hyperglycemia
16%
Research Design
16%
Immunology and Microbiology
Glucose Blood Level
100%
Insulin
66%
Insulin Release
33%
Insulin Allergy
33%
Drug Megadose
16%
Insulin Sensitivity
16%
Glucose Level
16%